Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$353.7K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 12 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 23 most recent Form 4 transactions.
| Jun 10 | IMNM | Immunome Inc. | AGRANT◆ | 9,897 | — | — | — | Open the original filing on SEC.gov |
| Jun 8 | INCY | Incyte Corp | AGRANT◆ | 6,111 | — | — | — | Open the original filing on SEC.gov |
| Jun 8 | INCY | Incyte Corp | AGRANT | 1,642 | — | — | +7.2% | Open the original filing on SEC.gov |
| Jun 5 | IMNM | Immunome Inc. | PBUY | 1,000 | $19.27 | $19.3K | +2.4% | Open the original filing on SEC.gov |
| Jun 5 | IMNM | Immunome Inc. | PBUY | 3,500 | $19.46 | $68.1K | +9.0% | Open the original filing on SEC.gov |
| Jun 5 | IMNM | Immunome Inc. | PBUY | 6,000 | $19.48 | $116.9K | +18.2% | Open the original filing on SEC.gov |
| Jun 5 | IMNM | Immunome Inc. | SSELL | 10,000 | $19.41 | $194.1K | -23.3% | Open the original filing on SEC.gov |
| Jun 5 | IMNM | Immunome Inc. | SSELL | 500 | $19.44 | $9.7K | -1.1% | Open the original filing on SEC.gov |
| Jun 3 | KROS | Keros Therapeutics, Inc. | AGRANT◆ | 7,433 | — | — | — | Open the original filing on SEC.gov |
| Jun 3 | KROS | Keros Therapeutics, Inc. | AGRANT | 7,142 | — | — | +75.6% | Open the original filing on SEC.gov |
| May 29 | ASND | Ascendis Pharma A/S | PBUY | 100 | $223.50 | $22.4K | +12.5% | Open the original filing on SEC.gov |
| May 29 | ASND | Ascendis Pharma A/S | PBUY | 200 | $222.30 | $44.5K | +33.3% | Open the original filing on SEC.gov |
| May 29 | ASND | Ascendis Pharma A/S | PBUY | 200 | $223.76 | $44.8K | +50.0% | Open the original filing on SEC.gov |
| May 26 | ASND | Ascendis Pharma A/S | PBUY | 200 | $239.37 | $47.9K | +100.0% | Open the original filing on SEC.gov |
| May 26 | ASND | Ascendis Pharma A/S | PBUY | 200 | $236.24 | $47.2K | — | Open the original filing on SEC.gov |
| May 26 | INCY | Incyte Corp | MEXER◷◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| May 26 | INCY | Incyte Corp | FTAX◷ | 13,059 | $97.10 | $1.3M | -36.4% | Open the original filing on SEC.gov |
| May 26 | INCY | Incyte Corp | MEXER◷ | 15,000 | $84.53 | $1.3M | +72.0% | Open the original filing on SEC.gov |
| May 15 | KROS | Keros Therapeutics, Inc. | PBUY◷ | 1,000 | $10.58 | $10.6K | +11.8% | Open the original filing on SEC.gov |
| May 15 | IMNM | Immunome Inc. | PBUY | 5,000 | $20.70 | $103.5K | +13.0% | Open the original filing on SEC.gov |
| Apr 15 | KROS | Keros Therapeutics, Inc. | PBUY◷ | 1,000 | $11.70 | $11.7K | +13.4% | Open the original filing on SEC.gov |